Live Vital Review – Very Cheap Tirzepatide, Very Little Public Record

Live Vital is a physician-guided cash-pay telehealth practice covering weight, hormone, recovery and longevity programmes for adults in all 50 states. Its compounded GLP-1 options start at $99 a month for semaglutide and $183 for tirzepatide — the latter among the cheapest we have catalogued anywhere. You complete an online intake, a licensed provider reviews it, and if a protocol is clinically appropriate the medication ships. Insurance is not billed, though HSA and FSA funds may apply. The catch is not the price; it is how little there is to verify.

Overview

Live Vital runs the standard telehealth flow with a broader catalogue than most: alongside GLP-1 weight loss it offers hormone, recovery and longevity protocols, including injectables. As with other multi-category providers, the evidence base thins considerably outside the GLP-1 line, and if you are here for weight loss there is no reason to add the rest.

HSA and FSA eligibility is worth noting — most compounded providers are silent on it, and being able to pay with pre-tax dollars is a real saving. See our HSA/FSA guide.

Live Vital at a Glance

Pricing: Among the Cheapest Tirzepatide

At $99, semaglutide matches the cheapest tier we track. At $183, tirzepatide undercuts most of the market comfortably — TrimRx charges $349, Shed $299, RNK Health $297 — though Embody at $119 and Trimi at $125 are cheaper still.

What is not published is whether these prices hold as your dose increases, what plan lengths apply, or what cancellation and refund terms look like. Given how many providers in this market quote a starting dose and scale upward, that is the first thing to establish.

The Questions Live Vital Tells You to Ask

The reason it matters now rather than in the abstract: the FDA resolved the tirzepatide shortage in October 2024 and the semaglutide shortage on 21 February 2025, and on 30 April 2026 proposed excluding semaglutide, tirzepatide and liraglutide from the 503B bulks list, with the comment period closing on 30 July 2026. Patient-specific 503A compounding remains lawful within narrow limits — a pharmacy may not regularly, or in inordinate amounts, compound what is essentially a copy of a commercially available drug.

"Patient-specific rationale" is the phrase doing the work. A compounded GLP-1 is supposed to exist because something about your case requires a preparation the approved product cannot provide — a different concentration, an excipient allergy — not simply because it is cheaper. Any provider should be able to answer that for your prescription. Our compounded vs brand-name guide explains the distinction.

Eligibility, Contraindications, and Side Effects

Live Vital serves adults in all 50 states and prescribes only where a provider judges a protocol clinically appropriate, but does not publish criteria. See our eligibility guide.

Semaglutide and tirzepatide carry a boxed warning regarding thyroid C-cell tumours, based on rodent studies. You should not take these medications if you or a family member have had medullary thyroid carcinoma, if you have Multiple Endocrine Neoplasia syndrome type 2, or if you have had a serious hypersensitivity reaction to the active ingredient. They are not for use in pregnancy. A history of pancreatitis, gallbladder disease, gastroparesis or other severe gastrointestinal disease, or diabetic retinopathy, warrants specific discussion first.

Common side effects are gastrointestinal — nausea, vomiting, diarrhoea, constipation and abdominal pain — worst after a dose increase. Serious but less common risks include pancreatitis, gallbladder disease and acute kidney injury from dehydration. Because Live Vital does not describe its ongoing care model, establish before paying how you would reach a clinician if a dose step goes badly. Our side effects guide covers management.

We are not quoting weight-loss figures for Live Vital, which publishes no outcome data of its own.

How Live Vital Compares

Trimi Health matches Live Vital's semaglutide price, beats it on tirzepatide by $58, names both its pharmacies and publishes 50-state coverage. On the published information there is no axis on which Live Vital is the better choice.

Pros and Cons

Who Should Pick It, and Who Should Look Elsewhere

Live Vital could suit you if you want cheap tirzepatide, you are able to pay with HSA or FSA funds, and you are comfortable being an early customer of a service with little public record. If you go ahead, take the coverage's own advice: ask about the legal basis, the formulation, the pharmacy and the patient-specific rationale before paying.

Look elsewhere if you want evidence behind the price. Trimi Health matches the semaglutide rate, beats the tirzepatide rate, and names its pharmacies. Cora Health costs a little more with a PCAB-accredited pharmacy and an established record.

Limitations of This Review

This review is based on the limited published information available for Live Vital, checked on 7 August 2026. We found essentially no independent customer review data and no BBB record, so service quality, shipping reliability and complaint handling are entirely untested here. The compounding pharmacy, dose pricing, cancellation terms, refund policy and eligibility criteria are all unpublished. We have not signed up or been prescribed. This rating reflects an unverifiable offer rather than any reported failure, and should be revisited if a record develops.

Frequently Asked Questions

Verdict

Live Vital's prices are good — $99 semaglutide matches the cheapest tier and $183 tirzepatide beats most of the market — and being able to use pre-tax dollars is a genuine advantage few compounded providers offer. But we rate providers on what a buyer can verify before paying, and here that is a price list and little else: no named pharmacy, no dose schedule, no cancellation terms, no review record. Trimi Health offers the same semaglutide price, cheaper tirzepatide and names its pharmacies, which makes it the easier recommendation until Live Vital publishes more.